Palonosetron to prevent nausea and vomiting in children undergoing BMT: efficacy and safety.
Ripaldi
M
M
Parasole
R
R
De Simone
G
G
D'Amico
M R
MR
Migliorati
R
R
Zanotta
G
G
Loffredo
G
G
Petruzziello
F
F
Poggi
V
V
D000293:Adolescent; D000932:Antiemetics / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000209:etiology / Q000517:prevention & control*; D009369:Neoplasms / Q000601:surgery; D000077924:Palonosetron; D011812:Quinuclidines / Q000627:therapeutic use*; D012189:Retrospective Studies; D012702:Serotonin Antagonists / Q000627:therapeutic use; D014839:Vomiting / Q000209:etiology / Q000517:prevention & control*
D000932:Antiemetics; D007546:Isoquinolines; D011812:Quinuclidines; D012702:Serotonin Antagonists; D000077924:Palonosetron